Question 1

What is the catalog number for BCI-121?

Accepted Answer

The catalog number for BCI-121 is B3251-25.

Question 2

Is BCI-121 in stock?

Accepted Answer

BCI-121 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What is BCI-121 used for?

Accepted Answer

BCI-121 is a substrate-competitive SMYD3 inhibitor that reduces nuclear histone H3 lys4 di- and tri-methylation level, downregulates known SMYD3 target genes transcription, and selectively affects SMYD3-dependent proliferation of cancer cultures with little antiproliferation efficacy toward low SMYD

Question 4

Is this product tested for endotoxin levels?

Accepted Answer

Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.

Question 5

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 6

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

BCI-121

Product Specifications

Shipping Conditions

Storage Conditions

Shelf Life

Frequently Asked Questions

Explore Other Products

Indole-3-carbinol

UBTD1 Antibody

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF740 conjugate, 0.1mg/mL

2-O-(p-Nitrophenyl)-Alpha-D-N-acetylneuraminic Acid, Sodium Salt, X Hydrate

Recombinant Human CD68/Macrosialin Protein (aa 1-319, His Tag)

rac-trans-[3-Hydroxycyclohexyl]benzamide